Thus, we further aimed to compare the binding efficiencies of annexin A5 and GlaS proteins to PS-exposing sEVs and m/lEVs, identified by CD63 or annexin A1 positivity, respectively, derived from cancer and non-cancerous cells using single EV flow cytometry. The gene discussed is CD63; the disease is cancer.